These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 24051942

  • 21. d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS.
    Cianci A, Panella M, Fichera M, Falduzzi C, Bartolo M, Caruso S.
    Gynecol Endocrinol; 2015 Jun; 31(6):483-6. PubMed ID: 25893270
    [Abstract] [Full Text] [Related]

  • 22. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 23. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
    Minozzi M, Nordio M, Pajalich R.
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
    [Abstract] [Full Text] [Related]

  • 24. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.
    Esfahanian F, Zamani MM, Heshmat R, Moini nia F.
    J Obstet Gynaecol Res; 2013 Apr; 39(4):806-13. PubMed ID: 23279603
    [Abstract] [Full Text] [Related]

  • 25. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [Abstract] [Full Text] [Related]

  • 26. The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial.
    Soldat-Stanković V, Popović-Pejičić S, Stanković S, Prtina A, Malešević G, Bjekić-Macut J, Livadas S, Ognjanović S, Mastorakos G, Micić D, Macut D.
    J Endocrinol Invest; 2022 Mar; 45(3):583-595. PubMed ID: 34665453
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients.
    Genazzani AD, Shefer K, Della Casa D, Prati A, Napolitano A, Manzo A, Despini G, Simoncini T.
    J Endocrinol Invest; 2018 May; 41(5):583-590. PubMed ID: 29090431
    [Abstract] [Full Text] [Related]

  • 29. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment.
    Jakubowska J, Bohdanowicz-Pawlak A, Milewicz A, Szymczak J, Bednarek-Tupikowska G, Demissie M.
    Gynecol Endocrinol; 2008 Jul; 24(7):378-84. PubMed ID: 18645710
    [Abstract] [Full Text] [Related]

  • 30. Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome.
    Fruzzetti F, Fidecicchi T, Palla G, Gambacciani M.
    Gynecol Endocrinol; 2020 Feb; 36(2):152-155. PubMed ID: 31317814
    [Abstract] [Full Text] [Related]

  • 31. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.
    Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, Cela V.
    Gynecol Endocrinol; 2013 Apr; 29(4):375-9. PubMed ID: 23336594
    [Abstract] [Full Text] [Related]

  • 32. Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth?
    Guarano A, Capozzi A, Cristodoro M, Di Simone N, Lello S.
    Nutrients; 2023 Jul 19; 15(14):. PubMed ID: 37513627
    [Abstract] [Full Text] [Related]

  • 33. Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome.
    Liao L, Tian YJ, Zhao JJ, Xin Y, Xing HY, Dong JJ.
    Chin Med J (Engl); 2011 Mar 19; 124(5):714-8. PubMed ID: 21518564
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA).
    Cirillo F, Catellani C, Lazzeroni P, Sartori C, Tridenti G, Vezzani C, Fulghesu AM, Madeddu E, Amarri S, Street ME.
    Gynecol Endocrinol; 2020 Jul 19; 36(7):588-593. PubMed ID: 32054355
    [Abstract] [Full Text] [Related]

  • 36. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.
    Raffone E, Rizzo P, Benedetto V.
    Gynecol Endocrinol; 2010 Apr 19; 26(4):275-80. PubMed ID: 20222840
    [Abstract] [Full Text] [Related]

  • 37. Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.
    Morgante G, Musacchio MC, Orvieto R, Massaro MG, De Leo V.
    Gynecol Endocrinol; 2013 Nov 19; 29(11):967-9. PubMed ID: 23957782
    [Abstract] [Full Text] [Related]

  • 38. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
    Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A.
    Gynecol Endocrinol; 2007 Dec 19; 23(12):700-3. PubMed ID: 17952759
    [Abstract] [Full Text] [Related]

  • 39. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH, von Eye Corleta H, Capp E, Spritzer PM.
    Horm Metab Res; 2003 Feb 19; 35(2):86-91. PubMed ID: 12734787
    [Abstract] [Full Text] [Related]

  • 40. The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome.
    Oppelt PG, Mueller A, Jentsch K, Kronawitter D, Reissmann C, Dittrich R, Beckmann MW, Cupisti S.
    Exp Clin Endocrinol Diabetes; 2010 Oct 19; 118(9):633-7. PubMed ID: 19998243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.